Andy Rasdal

Rasdal is the former CEO of DexCom Inc., a provider of a continuous glucose monitor product for diabetes. Prior to DexCom, he was president of Medtronic Vascular, and vice president of global marketing at Arterial Vascular Engineering Inc. (AVE) which was acquired by Medtronic. He also held leadership positions at EP Technologies, and Advanced Cardiovascular Systems.

  • March 2024

Added to: Synchron - Brooklyn, NY

Synchron is a neurotechnology company developing an endovascular brain-computer interface(BCI) designed to restore functionality in patients with severe paralysis.